The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Juergen Braun

Correspondence to Jürgen Braun

Rheumazentrum Ruhrgebiet

Landgrafenstrasse 15

D-44652 Herne

Germany;

[email]@rheumazentrum-ruhrgebiet.de

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Correspondence to Jürgen Braun, Rheumazentrum Ruhrgebiet, Landgrafenstrasse 15, D-44652 Herne, Germany;. 2002 - 2012
  • Rheumazentrum Ruhrgebiet, Herne, Germany. 2001 - 2010
  • Ruhr-University Bochum, Germany. 2007
  • Rheumazentrum Ruhrgebiet, Herne and University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany. 2005
  • Department of Gastroenterology/Rheumatology, Benjamin Franklin Hospital, Free University (FU) Berlin, Germany. 2004
  • Benjamin Franklin Hospital, Free University, Berlin, Germany. 2003

References

  1. Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study. Braun, J., Deodhar, A., Inman, R.D., van der Heijde, D., Mack, M., Xu, S., Hsu, B. Ann. Rheum. Dis. (2012) [Pubmed]
  2. Identifying patients with axial spondyloarthritis in primary care: how useful are items indicative of inflammatory back pain? Braun, A., Saracbasi, E., Grifka, J., Schnitker, J., Braun, J. Ann. Rheum. Dis. (2011) [Pubmed]
  3. Persistent clinical efficacy and safety of infliximab in ankylosing spondylitis after 8 years--early clinical response predicts long-term outcome. Baraliakos, X., Listing, J., Fritz, C., Haibel, H., Alten, R., Burmester, G.R., Krause, A., Schewe, S., Schneider, M., Sörensen, H., Schmidt, R., Sieper, J., Braun, J. Rheumatology. (Oxford) (2011) [Pubmed]
  4. Optimal administration and dosage of methotrexate. Braun, J. Clin. Exp. Rheumatol. (2010) [Pubmed]
  5. Clinical manifestations and responsiveness to adalimumab are similar in patients with ankylosing spondylitis with and without concomitant psoriasis. Braun, J., Rudwaleit, M., Kary, S., Kron, M., Wong, R.L., Kupper, H. Rheumatology. (Oxford) (2010) [Pubmed]
  6. Improvement in hemoglobin levels in patients with ankylosing spondylitis treated with infliximab. Braun, J., van der Heijde, D., Doyle, M.K., Han, C., Deodhar, A., Inman, R., de Vlam, K., Burmester, G.R., Van den Bosch, F., Xu, S., Visvanathan, S., Rahman, M.U. Arthritis Rheum. (2009) [Pubmed]
  7. Biologics in the treatment of rheumatoid arthritis and ankylosing spondylitis. Braun, J., Kalden, J.R. Clin. Exp. Rheumatol. (2009) [Pubmed]
  8. Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period. Braun, J., Deodhar, A., Dijkmans, B., Geusens, P., Sieper, J., Williamson, P., Xu, W., Visvanathan, S., Baker, D., Goldstein, N., van der Heijde, D. Arthritis Rheum. (2008) [Pubmed]
  9. Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial. Braun, J., Kästner, P., Flaxenberg, P., Währisch, J., Hanke, P., Demary, W., von Hinüber, U., Rockwitz, K., Heitz, W., Pichlmeier, U., Guimbal-Schmolck, C., Brandt, A. Arthritis Rheum. (2008) [Pubmed]
  10. Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response. Braun, J., Baraliakos, X., Listing, J., Fritz, C., Alten, R., Burmester, G., Krause, A., Schewe, S., Schneider, M., Sörensen, H., Zeidler, H., Sieper, J. Ann. Rheum. Dis. (2008) [Pubmed]
  11. Canadian recommendations for the management of spondyloarthritis address many different levels of patient care. Braun, J. Nature Clinical Practice. Rheumatology (2008) [Pubmed]
  12. Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents. Braun, J., Baraliakos, X., Listing, J., Davis, J., van der Heijde, D., Haibel, H., Rudwaleit, M., Sieper, J. Arthritis Rheum. (2007) [Pubmed]
  13. Ankylosing spondylitis. Braun, J., Sieper, J. Lancet (2007) [Pubmed]
  14. First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Braun, J., Davis, J., Dougados, M., Sieper, J., van der Linden, S., van der Heijde, D. Ann. Rheum. Dis. (2006) [Pubmed]
  15. Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial. Braun, J., Zochling, J., Baraliakos, X., Alten, R., Burmester, G., Grasedyck, K., Brandt, J., Haibel, H., Hammer, M., Krause, A., Mielke, F., Tony, H.P., Ebner, W., Gömör, B., Hermann, J., Zeidler, H., Beck, E., Baumgaertner, M., Sieper, J. Ann. Rheum. Dis. (2006) [Pubmed]
  16. Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study. Braun, J., Landewé, R., Hermann, K.G., Han, J., Yan, S., Williamson, P., van der Heijde, D. Arthritis Rheum. (2006) [Pubmed]
  17. Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis. Braun, J., Brandt, J., Listing, J., Zink, A., Alten, R., Burmester, G., Gromnica-Ihle, E., Kellner, H., Schneider, M., Sörensen, H., Zeidler, H., Sieper, J. Ann. Rheum. Dis. (2005) [Pubmed]
  18. Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years. Braun, J., Baraliakos, X., Brandt, J., Listing, J., Zink, A., Alten, R., Burmester, G., Gromnica-Ihle, E., Kellner, H., Schneider, M., Sörensen, H., Zeidler, H., Sieper, J. Rheumatology. (Oxford) (2005) [Pubmed]
  19. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Braun, J., Baraliakos, X., Listing, J., Sieper, J. Arthritis Rheum. (2005) [Pubmed]
  20. Therapy of ankylosing spondylitis--a review. Part I: Conventional medical treatment and surgical therapy. Braun, J., Baraliakos, X., Godolias, G., Böhm, H. Scand. J. Rheumatol. (2005) [Pubmed]
  21. Therapy of ankylosing spondylitis. Part II: biological therapies in the spondyloarthritides. Braun, J., Baraliakos, X., Brandt, J., Sieper, J. Scand. J. Rheumatol. (2005) [Pubmed]
  22. Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanercept. Brandt, J., Khariouzov, A., Listing, J., Haibel, H., Sörensen, H., Rudwaleit, M., Sieper, J., Braun, J. J. Rheumatol. (2004) [Pubmed]
  23. Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems. Braun, J., Baraliakos, X., Golder, W., Hermann, K.G., Listing, J., Brandt, J., Rudwaleit, M., Zuehlsdorf, S., Bollow, M., Sieper, J., van der Heijde, D. Ann. Rheum. Dis. (2004) [Pubmed]
  24. Biological therapies in the spondyloarthritides--the current state. Braun, J., Sieper, J. Rheumatology. (Oxford) (2004) [Pubmed]
  25. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Braun, J., Baraliakos, X., Golder, W., Brandt, J., Rudwaleit, M., Listing, J., Bollow, M., Sieper, J., Van Der Heijde, D. Arthritis Rheum. (2003) [Pubmed]
  26. Overview of the use of the anti-TNF agent infliximab in chronic inflammatory diseases. Braun, J., Sieper, J. Expert. Opin. Biol. Ther (2003) [Pubmed]
  27. Biologic therapies in the spondyloarthritis: new opportunities, new challenges. Braun, J., Brandt, J., Listing, J., Rudwaleit, M., Sieper, J. Curr. Opin. Rheumatol (2003) [Pubmed]
  28. Novel approaches in the treatment of ankylosing spondylitis and other spondyloarthritides. Braun, J., van der Heijde, D. Expert. Opin. Investig. Drugs (2003) [Pubmed]
  29. Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial. Braun, J., Brandt, J., Listing, J., Zink, A., Alten, R., Burmester, G., Golder, W., Gromnica-Ihle, E., Kellner, H., Schneider, M., Sörensen, H., Zeidler, H., Reddig, J., Sieper, J. Arthritis Rheum. (2003) [Pubmed]
  30. Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches. Braun, J., Sieper, J. Arthritis Res. (2002) [Pubmed]
  31. Staging of patients with ankylosing spondylitis: a preliminary proposal. Braun, J., van der Heijde, D., Dougados, M., Emery, P., Khan, M.A., Sieper, J., van der Linden, S. Ann. Rheum. Dis. (2002) [Pubmed]
  32. Anti-tumour necrosis factor alpha therapy for ankylosing spondylitis: international experience. Braun, J., Sieper, J., Breban, M., Collantes-Estevez, E., Davis, J., Inman, R., Marzo-Ortega, H., Mielants, H. Ann. Rheum. Dis. (2002) [Pubmed]
  33. Building consensus on nomenclature and disease classification for ankylosing spondylitis: results and discussion of a questionnaire prepared for the International Workshop on New Treatment Strategies in Ankylosing Spondylitis, Berlin, Germany, 18-19 January 2002. Braun, J., Sieper, J. Ann. Rheum. Dis. (2002) [Pubmed]
  34. New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti-tumor necrosis factor therapy. Braun, J., de Keyser, F., Brandt, J., Mielants, H., Sieper, J., Veys, E. Curr. Opin. Rheumatol (2001) [Pubmed]
 
WikiGenes - Universities